http://rdf.ncbi.nlm.nih.gov/pubchem/patent/HU-E029733-T2
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_42e94091a4fc81b8d0237117707cc7ee |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D417-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D513-04 |
| filingDate | 2006-07-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f10441d4cb76b10416ed28b727c579a4 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_59dc9bd803c88b375cd2405c2702c8ef http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_19734414d5b2ae286bc24060d353bf2e |
| publicationDate | 2017-03-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | HU-E029733-T2 |
| titleOfInvention | Benzothiazole and azabenzothiazole compounds as kinase inhibitors |
| abstract | A compound of Formula (I)n nor nan enantiomer, diastereomer or a pharmaceutically-acceptable salt thereof, wherein A is independently selected from:n nfurther wherein R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , R 7 , and W are as described herein. n Also disclosed are pharmaceutical compositions containing compounds of Formula (I), and the use of said compounds for treating conditions associated with the activity of p38 kinase. |
| priorityDate | 2005-08-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 805.